Will Mauldin, Ph.D. — Chairman, CEO, and Co‑founder at RIVANNA — emphasizes the need to overcome the long-standing challenges of real-time needle visualization in neuraxial anesthesia. Traditional ultrasound-guided procedures face two key barriers:
🚫 the clinician’s requirement for “three hands” to handle the probe, needle, and syringe
🚫 the probe is on midline, where the clinician needs to advance the needle
The motivation: Our customers and the anesthesia market have told us they want to continually visualize the needle in real time.
Follow us for more updates on Accuro 3S technology enabling real-time needle visualization in neuraxial anesthesia.